Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Touchon

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Science Bulletin|October 23, 2024
Now and future: Strategies for diagnosis, prevention and therapies for Alzheimer's diseaseJiong Shi, Jacques Touchon, Lefkos T Middleton, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2016
Limiting Factors of Brain Donation in Neurodegenerative Diseases: The Example of French Memory ClinicsRaphael Le Bouc, Cecilia Marelli, Emilie Beaufils, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 3, 2010
Insomnia symptoms in older adults: associated factors and gender differencesIsabelle Jaussent, Yves Dauvilliers, Marie-Laure Ancelin, et al.
The Journal of Prevention of Alzheimer'S Disease|April 26, 2025
Brain photobiomodulation: a potential treatment in Alzheimer's and Parkinson's diseasesGuillaume Blivet, Benjamin Touchon, Hugo Cavadore, et al.
Journal of Proteome Research|September 9, 2008
Enhanced detection of CNS cell secretome in plasma protein-depleted cerebrospinal fluidEric Thouvenot, Serge Urbach, Christelle Dantec, et al.
Current Alzheimer Research|June 24, 2016
MCI Patients in Europe: Medication and Comorbidities. The DESCRIPA StudyMagda Tsolaki, Vasileios Papaliagkas, Giovanni Frisoni, et al.
The Journal of Clinical Endocrinology and Metabolism|September 3, 2010
Metabolic syndrome, its components, and mortality in the elderlyTasnime N Akbaraly, Mika Kivimaki, Marie-Laure Ancelin, et al.
Journal of Neurology|September 26, 2006
Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's diseaseKathy Dujardin, David Devos, Stéphane Duhem, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2014
Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderlyAudrey Gabelle, Susanna Schraen, Laure-Anne Gutierrez, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Late-onset behavioral variant of frontotemporal lobar degeneration versus Alzheimer's disease: Interest of cerebrospinal fluid biomarker ratiosCecilia Marelli, Laure-Anne Gutierrez, Nicolas Menjot de Champfleur, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Science Bulletin|October 23, 2024
Now and future: Strategies for diagnosis, prevention and therapies for Alzheimer's diseaseJiong Shi, Jacques Touchon, Lefkos T Middleton, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2016
Limiting Factors of Brain Donation in Neurodegenerative Diseases: The Example of French Memory ClinicsRaphael Le Bouc, Cecilia Marelli, Emilie Beaufils, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 3, 2010
Insomnia symptoms in older adults: associated factors and gender differencesIsabelle Jaussent, Yves Dauvilliers, Marie-Laure Ancelin, et al.
The Journal of Prevention of Alzheimer'S Disease|April 26, 2025
Brain photobiomodulation: a potential treatment in Alzheimer's and Parkinson's diseasesGuillaume Blivet, Benjamin Touchon, Hugo Cavadore, et al.
Journal of Proteome Research|September 9, 2008
Enhanced detection of CNS cell secretome in plasma protein-depleted cerebrospinal fluidEric Thouvenot, Serge Urbach, Christelle Dantec, et al.
Current Alzheimer Research|June 24, 2016
MCI Patients in Europe: Medication and Comorbidities. The DESCRIPA StudyMagda Tsolaki, Vasileios Papaliagkas, Giovanni Frisoni, et al.
The Journal of Clinical Endocrinology and Metabolism|September 3, 2010
Metabolic syndrome, its components, and mortality in the elderlyTasnime N Akbaraly, Mika Kivimaki, Marie-Laure Ancelin, et al.
Journal of Neurology|September 26, 2006
Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's diseaseKathy Dujardin, David Devos, Stéphane Duhem, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2014
Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderlyAudrey Gabelle, Susanna Schraen, Laure-Anne Gutierrez, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Late-onset behavioral variant of frontotemporal lobar degeneration versus Alzheimer's disease: Interest of cerebrospinal fluid biomarker ratiosCecilia Marelli, Laure-Anne Gutierrez, Nicolas Menjot de Champfleur, et al.
Pageof 9